Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus

NCT03527472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: Memantine
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]